<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/53944FC7-FD00-407E-A4F1-F22812C85420"><gtr:id>53944FC7-FD00-407E-A4F1-F22812C85420</gtr:id><gtr:name>University of Buckingham</gtr:name><gtr:address><gtr:line1>Hunter Street</gtr:line1><gtr:line4>Buckingham</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK18 1EG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7E9FA6C1-AE4C-428E-AD55-646632799B3D"><gtr:id>7E9FA6C1-AE4C-428E-AD55-646632799B3D</gtr:id><gtr:name>University Hospitals of Dusseldorf</gtr:name><gtr:address><gtr:line1>Moorenstrasse 5</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:department>Clinical Sciences</gtr:department><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A0A585E0-6B0D-4643-A3A6-47943B4CBFEF"><gtr:id>A0A585E0-6B0D-4643-A3A6-47943B4CBFEF</gtr:id><gtr:name>University of Liverpool</gtr:name><gtr:address><gtr:line1>Senate House</gtr:line1><gtr:line2>Abercromby Square</gtr:line2><gtr:line4>Liverpool</gtr:line4><gtr:postCode>L69 3BX</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A8F2AA65-FB13-45D8-96BA-E478CE387554"><gtr:id>A8F2AA65-FB13-45D8-96BA-E478CE387554</gtr:id><gtr:name>Karolinska University Hospital</gtr:name><gtr:address><gtr:line1>Karolinska University Hospital</gtr:line1><gtr:line2>Huddinge</gtr:line2><gtr:postCode>SE 141 86</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/53944FC7-FD00-407E-A4F1-F22812C85420"><gtr:id>53944FC7-FD00-407E-A4F1-F22812C85420</gtr:id><gtr:name>University of Buckingham</gtr:name><gtr:address><gtr:line1>Hunter Street</gtr:line1><gtr:line4>Buckingham</gtr:line4><gtr:line5>Buckinghamshire</gtr:line5><gtr:postCode>MK18 1EG</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7E9FA6C1-AE4C-428E-AD55-646632799B3D"><gtr:id>7E9FA6C1-AE4C-428E-AD55-646632799B3D</gtr:id><gtr:name>University Hospitals of Dusseldorf</gtr:name><gtr:address><gtr:line1>Moorenstrasse 5</gtr:line1><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0E3923DA-27B7-4AEC-AE5D-72D7034A6771"><gtr:id>0E3923DA-27B7-4AEC-AE5D-72D7034A6771</gtr:id><gtr:firstName>Chen</gtr:firstName><gtr:surname>Bing</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/6FE375B7-582A-4E68-B5C2-7BD8E6AC5E95"><gtr:id>6FE375B7-582A-4E68-B5C2-7BD8E6AC5E95</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:surname>Trayhurn</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0801226"><gtr:id>5A6C39F8-B65E-4945-AD30-A042121BF9C1</gtr:id><gtr:title>Role of zinc-alpha2-glycoprotein in the prevention of adipose tissue expansion by modulating the adipogenic programme</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0801226</gtr:grantReference><gtr:abstractText>Increased body fat in obesity has a strong link to insulin resistance, type-2 diabetes and heart disease. Too much fat in obesity results from a combination of increased lipid storage in existing fat cells and the generation of new fat cells from precursors cells. Recently, the direct importance of fat tissue in the control of body weight has become recognised. This is because the fat cells, in addition to lipid storage, can produce a wide range of proteins that regulate the total amount of body fat and different biological processes, including appetite and metabolism. Our recent work has found that a protein called zinc-alpha2-glycoprotein (ZAG) is also made by fat cells. ZAG production in fat cells is inversely related to the amount of body fat, being reduced in obesity while greatly increased in mice with little fat. Our subsequent work in these mice indicates that overproduction of ZAG is associated with a major reduction in several key genes and proteins involved in making new fat cells. However, it is unclear whether ZAG acts directly to influence this process. The aim of this project is to test our new idea that ZAG has a major role in limiting the expansion of fat mass, especially in the control of the number of fat cells and lipid accumulation during the formation of new fat cells. To examine this idea, we will study to what extent ZAG modifies the early and late events of making new fat cells, by analysing the effects of ZAG on the key factors, particularly those promoting fat cell formation and development. We will also examine whether ZAG influences lipid storing capacity through altering lipid accumulation in fat cells, and whether ZAG treatment reduces fat mass expansion in obesity, using an obese mouse model. Given, the current high interest in body fat regulation, clarification of the mechanisms by which ZAG hinders fat cell formation will give important new insights into the control of body fat. Recently, a report by the UK Government Foresight Group has suggested that Britain could be a mainly obese society by 2050; this research is therefore very timely and the findings may ultimately lead to new treatments for protecting against body fat accumulation in obesity. The progress and findings of this research will be transmitted to the general public through publications, meetings, press releases by the University and public awareness events.</gtr:abstractText><gtr:technicalSummary>The importance of white adipose tissue in the control of energy homeostasis is now firmly recognised. 
In addition to fuel storage, adipocytes secrete an array of proteins (adipokines) which modulate multiple physiological and metabolic processes. Disorders of adipocyte formation and function, such as abnormal adipose expansion in obesity, predisposes to insulin resistance, type-2 diabetes and cardiovascular disease. The excess of body fat in obesity results from a combination of increased lipid storage in existing adipocytes and the generation of new adipocytes from precursors residing within the adipose tissue. The latter cellular process, termed adipogenesis, involves transcriptional control of preadipocyte differentiation and adipocyte maturation, which are influenced by hormones and signalling factors. Recent work from our group has identified zinc-a2-glycoprotein (ZAG) as a novel adipokine. ZAG expression in adipose tissue is inversely related to the expansion of fat mass, being reduced in obesity while upregulated in cancer cachexia. Our subsequent work has demonstrated that ZAG overproduction in cachexia, is associated with adipose atrophy and a major reduction of gene transcripts encoding several key adipogenic factors. However, whether ZAG functions directly to inhibit adipogenesis has not been identified. This research aims to investigate a proposed novel function of ZAG in adipose tissue, specifically adipocyte differentiation through targeting the induction of key adipogenic factors. The main specific objectives are to study: (1) whether ZAG inhibits the transcriptional control of early and late events of the adipogenic programme, and the signalling pathways involved, employing murine and human adipocytes with ZAG overexpression; (2) whether ZAG affects lipid accumulation in differentiated adipocytes and antagonises the maintenance of the adipocyte phenotype, using ZAG gene transfection; (3) whether ZAG modulates adipocyte lipid storage capacity with lipogenic analysis; (4) whether ZAG restrains adipose tissue expansion in obesity, using obese (ob/ob) mice treated with recombinant ZAG; (5) whether ZAG knockdown with siRNA enhances lipid accumulation and fatty acid synthesis in human adipocytes; (6) whether forced expression of the key adipogenic factors reverses the effects of ZAG. Given the escalation in obesity and its associated type-2 diabetes, this work is timely and important. Clarification that ZAG has a major role in adipogenesis will give new insights into adipocyte regulation and function. Findings from this research will have clinical importance in providing a better understanding of fat mass expansion in obesity and also severe fat loss in cachexia.</gtr:technicalSummary><gtr:fund><gtr:end>2012-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>308629</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Buckingham</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Diabetes, Obesity and Metabolic Disease</gtr:department><gtr:description>ZAG in energy balance</gtr:description><gtr:id>1F52BC6D-39D9-43AA-9921-F5C2D050CBAE</gtr:id><gtr:impact>PMID: 19934249</gtr:impact><gtr:outcomeId>Z7QnE7AYMZK-1</gtr:outcomeId><gtr:piContribution>a. significant intellectual input;
b. generate recombinant ZAG protein;</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Karolinska University Hospital</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>ZAG and fat loss</gtr:description><gtr:id>5CF80394-5970-4019-902E-6C70354B448C</gtr:id><gtr:impact>PMID:21245862</gtr:impact><gtr:outcomeId>TMpKCUVsa6p-2</gtr:outcomeId><gtr:partnerContribution>significant intellectual input 
access data1. intellectual input;
2. access to data</gtr:partnerContribution><gtr:piContribution>1. significant intellectual input;
2. carried out experiments and data analysis;
3. draft and finalise the publication</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>College of Medicine &amp; Veterinary Medicine</gtr:department><gtr:description>ZAG and fat loss</gtr:description><gtr:id>92D8751D-1F94-409E-96F0-6CB222360732</gtr:id><gtr:impact>PMID:21245862</gtr:impact><gtr:outcomeId>TMpKCUVsa6p-1</gtr:outcomeId><gtr:partnerContribution>significant intellectual input 
access data1. intellectual input;
2. access to data</gtr:partnerContribution><gtr:piContribution>1. significant intellectual input;
2. carried out experiments and data analysis;
3. draft and finalise the publication</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University Hospital D?sseldorf</gtr:collaboratingOrganisation><gtr:country>Germany, Federal Republic of</gtr:country><gtr:department>German Diabetes Center</gtr:department><gtr:description>ZAG and skeletal muscle</gtr:description><gtr:id>1B621788-5703-4726-AC4F-CB8FC419F0E7</gtr:id><gtr:impact>PMID:21457004
PMID:21158485</gtr:impact><gtr:outcomeId>VF48tmZuohC-1</gtr:outcomeId><gtr:piContribution>a. intellectual input into your collaborators research;
b. generate recombinant ZAG protein</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School and public</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>FC810B65-15C0-4E8D-97DD-8F98AE2CF719</gtr:id><gtr:impact>Over a hundred audience including pupils and lay public attended meeting, which sparked questions and discussion.

During discussion, some pupils expressed their interests in studying biomedical science.</gtr:impact><gtr:outcomeId>kVmFsj7yPV5</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2009,2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>6000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Project grant/Diabetes Research Wellness Foundation</gtr:description><gtr:end>2011-12-02</gtr:end><gtr:fundingOrg>The Diabetes Research &amp; Wellness Foundation</gtr:fundingOrg><gtr:id>6E62F6E6-4311-4D48-A536-278FC0C96F06</gtr:id><gtr:outcomeId>gSgVkc9w7Q50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have developmed a method for generating recombinant human ZAG protein, which was via transfection of the human ZAG gene using HEK293 cells.</gtr:description><gtr:id>4A2B0431-4CF8-49ED-846E-E6A41A00663D</gtr:id><gtr:impact>This allows us to study ZAG functions in vitro and in vivo. We have also established research collaborations using recombinant ZAG to study the effects of the protein on energy expenditure (with Buckingham University, UK), insulin sensitivity in skeletal muscle (German Diabetes Center, Germany), lipolysis in human adipocytes (Karolinska Institute, Sweden), and cancer cell proliferation and apoptosis (Clermont University, France).
The collaboration with German diabetes Center and Buckingham University has led to two journal publications (2011, 2012).</gtr:impact><gtr:outcomeId>GKa8Rq42s87</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Recombinant ZAG</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2010</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D0F5758D-32E1-4DA5-8A3D-ADA60F5F8F7D</gtr:id><gtr:title>Downregulation of zinc-{alpha}2-glycoprotein in adipose tissue and liver of obese ob/ob mice and by tumour necrosis factor-alpha in adipocytes.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245f49b97d48361c5409b32dbacf3153"><gtr:id>245f49b97d48361c5409b32dbacf3153</gtr:id><gtr:otherNames>Mracek T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>sDbSmAqntAu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A71371C-850B-4383-9750-09580A174ACA</gtr:id><gtr:title>Is interleukin-1? a culprit in macrophage-adipocyte crosstalk in obesity?</gtr:title><gtr:parentPublicationTitle>Adipocyte</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d494ef038ece2fdbdd7b435e84033146"><gtr:id>d494ef038ece2fdbdd7b435e84033146</gtr:id><gtr:otherNames>Bing C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2162-3945</gtr:issn><gtr:outcomeId>56af776e996cc6.37731574</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>38A19C04-2FCC-4A88-B68F-49CD54D83905</gtr:id><gtr:title>Upregulation of the expression of inflammatory and angiogenic markers in human adipocytes by a synthetic cannabinoid, JTE-907.</gtr:title><gtr:parentPublicationTitle>Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e59d69bf1c90c8d4abd9610fc41400d1"><gtr:id>e59d69bf1c90c8d4abd9610fc41400d1</gtr:id><gtr:otherNames>Gonz?lez-Muniesa P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0018-5043</gtr:issn><gtr:outcomeId>D6edT67agX5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>50BB1F84-39BA-4752-98E6-A299F63D8A7E</gtr:id><gtr:title>Macrophage-induced expression and release of matrix metalloproteinase 1 and 3 by human preadipocytes is mediated by IL-1? via activation of MAPK signaling.</gtr:title><gtr:parentPublicationTitle>Journal of cellular physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d7e81f5c91b8c91b6b9a9515c59411"><gtr:id>95d7e81f5c91b8c91b6b9a9515c59411</gtr:id><gtr:otherNames>Gao D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0021-9541</gtr:issn><gtr:outcomeId>jJJVB1s87TM</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E23E2131-AF18-42F0-A94D-42714BB43AD9</gtr:id><gtr:title>1,25-Dihydroxyvitamin D3 inhibits the cytokine-induced secretion of MCP-1 and reduces monocyte recruitment by human preadipocytes.</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d7e81f5c91b8c91b6b9a9515c59411"><gtr:id>95d7e81f5c91b8c91b6b9a9515c59411</gtr:id><gtr:otherNames>Gao D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>pm_12917_27_22508334</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>66283186-6467-497E-BDBF-B5FF75131F69</gtr:id><gtr:title>Secreted proteins from adipose tissue and skeletal muscle - adipokines, myokines and adipose/muscle cross-talk.</gtr:title><gtr:parentPublicationTitle>Archives of physiology and biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/af2c9411ed340d4e2e2d2cde5bf85ffe"><gtr:id>af2c9411ed340d4e2e2d2cde5bf85ffe</gtr:id><gtr:otherNames>Trayhurn P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1381-3455</gtr:issn><gtr:outcomeId>ChgzweBpL8Y</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A397C3F0-F35E-45E7-90F8-CA6BE47190AD</gtr:id><gtr:title>Contrasts between the effects of zinc-a2-glycoprotein, a putative ?3/2-adrenoceptor agonist and the ?3/2-adrenoceptor agonist BRL35135 in C57Bl/6 (ob/ob) mice.</gtr:title><gtr:parentPublicationTitle>The Journal of endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/aa803630a45956d21713cd35706341bc"><gtr:id>aa803630a45956d21713cd35706341bc</gtr:id><gtr:otherNames>Wargent ET</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-0795</gtr:issn><gtr:outcomeId>pm_12917_27_23151357</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BABCF5AD-0318-4901-9832-E4EAA878BB9E</gtr:id><gtr:title>Circulating anti-inflammatory adipokines High Molecular Weight Adiponectin and Zinc-a2-glycoprotein (ZAG) are inhibited in early sepsis, but increase with clinical recovery: a pilot study.</gtr:title><gtr:parentPublicationTitle>BMC anesthesiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fae7b5b63068da85235959d08445e7f1"><gtr:id>fae7b5b63068da85235959d08445e7f1</gtr:id><gtr:otherNames>Welters ID</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1471-2253</gtr:issn><gtr:outcomeId>56af7a5b741b65.10301460</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5C1EFE9F-4CAD-4AB2-B92F-FEB8C6E5D6E8</gtr:id><gtr:title>Vitamin D signalling in adipose tissue.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97ebe4c849308af92af25e94a2557410"><gtr:id>97ebe4c849308af92af25e94a2557410</gtr:id><gtr:otherNames>Ding C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>pm_12917_27_23046765</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB68AF81-13E2-471B-9B88-CC884742EB2C</gtr:id><gtr:title>Lipid mobilization in cachexia: mechanisms and mediators.</gtr:title><gtr:parentPublicationTitle>Current opinion in supportive and palliative care</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d494ef038ece2fdbdd7b435e84033146"><gtr:id>d494ef038ece2fdbdd7b435e84033146</gtr:id><gtr:otherNames>Bing C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1751-4258</gtr:issn><gtr:outcomeId>R9SZpz9kgQr</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3735D098-9072-4603-B4A6-50B5BF02F9FB</gtr:id><gtr:title>The adipokine zinc-a2-glycoprotein activates AMP kinase in human primary skeletal muscle cells.</gtr:title><gtr:parentPublicationTitle>Archives of physiology and biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01199cd92c2a732a4a6f90526b515bef"><gtr:id>01199cd92c2a732a4a6f90526b515bef</gtr:id><gtr:otherNames>Eckardt K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1381-3455</gtr:issn><gtr:outcomeId>GEx17x7ngFi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AB93D58-3019-45D8-A559-DAC045DFFA8C</gtr:id><gtr:title>Enhanced ZAG production by subcutaneous adipose tissue is linked to weight loss in gastrointestinal cancer patients.</gtr:title><gtr:parentPublicationTitle>British journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/245f49b97d48361c5409b32dbacf3153"><gtr:id>245f49b97d48361c5409b32dbacf3153</gtr:id><gtr:otherNames>Mracek T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-0920</gtr:issn><gtr:outcomeId>pWjJ8L34UhN</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>87817B59-8DFA-4BD9-A9AE-B69CF0738C31</gtr:id><gtr:title>Lactate and the GPR81 receptor in metabolic regulation: implications for adipose tissue function and fatty acid utilisation by muscle during exercise.</gtr:title><gtr:parentPublicationTitle>The British journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33c740c61981ce9cde34f1abb4ae7ced"><gtr:id>33c740c61981ce9cde34f1abb4ae7ced</gtr:id><gtr:otherNames>Rooney K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0007-1145</gtr:issn><gtr:outcomeId>aensuCBEmCu</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>749948E0-DD60-40A1-B467-FA04C145D1CF</gtr:id><gtr:title>Macrophage-secreted factors inhibit ZAG expression and secretion by human adipocytes.</gtr:title><gtr:parentPublicationTitle>Molecular and cellular endocrinology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d7e81f5c91b8c91b6b9a9515c59411"><gtr:id>95d7e81f5c91b8c91b6b9a9515c59411</gtr:id><gtr:otherNames>Gao D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0303-7207</gtr:issn><gtr:outcomeId>gTzJLKLk3g1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>402D256E-0CB1-46C8-8F82-20C8252FA43A</gtr:id><gtr:title>Zinc-a2-glycoprotein: an adipokine modulator of body fat mass?</gtr:title><gtr:parentPublicationTitle>International journal of obesity (2005)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d494ef038ece2fdbdd7b435e84033146"><gtr:id>d494ef038ece2fdbdd7b435e84033146</gtr:id><gtr:otherNames>Bing C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0307-0565</gtr:issn><gtr:outcomeId>r17N8fqCmdd</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>76667B67-7073-4EAA-99C9-7A048D56AD17</gtr:id><gtr:title>Interleukin-1? mediates macrophage-induced impairment of insulin signaling in human primary adipocytes.</gtr:title><gtr:parentPublicationTitle>American journal of physiology. Endocrinology and metabolism</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/95d7e81f5c91b8c91b6b9a9515c59411"><gtr:id>95d7e81f5c91b8c91b6b9a9515c59411</gtr:id><gtr:otherNames>Gao D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0193-1849</gtr:issn><gtr:outcomeId>54524849864e64.95712439</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0801226</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D4FDB752-4E9C-491F-9C63-B7D7F6F95417</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Cardiovascular</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>160D22D0-5677-4513-A0AC-7F3526B7F336</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Metabolic and Endocrine</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>D81A471F-556F-4570-BF6A-5D197943223C</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Oral and Gastrointestinal</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>A77DAE3A-499B-4F46-971D-6C82F51F9C2E</gtr:id><gtr:percentage>20</gtr:percentage><gtr:text>Stroke</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>